•  
  •  
 

Abstract

Background: Drug-induced hypersensitivity syndrome (DIHS) is a rare and severe systemic drug reaction characterized by skin involvement, internal organ complications, and hematologic disorders. Management of this condition is challenging due to its wide range of cutaneous manifestations and 10% mortality rate.

Case Illustration: A 52-year-old male presented with widespread redness throughout his body with a prior history of regular phenytoin consumption. The rash continued to spread despite the patient’s abrupt discontinuation of the suspected medication. He was diagnosed with atypical DIHS according to J-SCAR criteria and was given high-dose corticosteroid. Drastic clinical improvement was observed after nine days of therapy, and complete resolution of the rash was achieved after 14 days. The steroid was stopped after four weeks, and no relapse was observed after four months of follow-up.

Discussion: Discontinuing the suspected medication is the first crucial step in DIHS management. No specific pharmaceutical strategy has been established for this syndrome; however, systemic corticosteroids have been frequently prescribed as a first-line therapy. Steroids need to be tapered off slowly over 6–8 weeks, even upon clinical resolution, to prevent relapse. In the current case, the steroid was tapered off slowly over four weeks. The lack of relapse observed after steroid discontinuation could be due to the fact that the patient stopped consuming the suspected medication immediately.

Conclusion: Education on the consequences of prescribing high-risk medications is important. Early detection and prompt cessation of offending medications are needed for better DIHS outcomes.

References

  1. Kardaun SH. Drug reaction with eosinophilia and systemic symptoms (DRESS). In: Shear NH, Dodiuk-Gad RP, editors. Advances in diagnosis and management of cutaneous adverse drug reactions: Current and future trends. Singapore: Springer Singapore; 2019. p.87–104.
  2. Wei BM, Fox LP, Kaffenberger BH, et al. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. J Am Acad Dermatol. 2024;90(5):885–908.
  3. Hama N, Abe R, Gibson A, Phillips EJ. Drug-induced hypersensitivity syndrome (DIHS)/ drug reaction with eosinophilia and systemic symptoms (DRESS): Clinical features and pathogenesis. J Allergy Clin Immunol Pract. 2022;10(5):1155–67.
  4. Rodrigues MNM, Cabreira JA, Nobre RK. Phenytoin induced drug reaction with eosinophilia and systemic symptoms (DRESS): Case report. Case Reports in Clinical Medicine. 2020;9(11):343–53.
  5. Indu TH, Basutkar RS. Hypersensitivity reaction associated with phenytoin. J Basic Clin Pharm. 2015;6(4):119–21.
  6. Besli GE, Yildirim S, Yilmaz K, Yuksel E. DRESS syndrome or hematologic malignancy?: A case report of a 4-year-old boy. Pediatr Emerg Care. 2017;33(7):494–6.
  7. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15(4):250–7.
  8. Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): An interplay among drugs, viruses, and immune system. Int J Mol Sci. 2017;18(6):1–21.
  9. Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019;68(3):301–8.
  10. Broccolo F, Ciccarese G, Agnoletti AF, et al. Telaprevir-induced moderate cutaneous eruptions associated with HHV-6 reactivation. J Med Virol. 2015;87(12):1985–6.
  11. Verstegen RHJ, Phillips EJ, Juurlink DN. First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroids. Front Med (Lausanne). 2023;10:1–3.
  12. De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature. Indian J Dermatol. 2018;63(1):30–40.

Download

Share

COinS